Table 4. Associations between selected subject characteristics and tuberculin skin test or QuantiFERON®-TB Gold In-Tube test results.
TST ≥ 15 mm | Positive QFT-GIT | TST ≥ 10 mma | |||||
---|---|---|---|---|---|---|---|
Characteristic | N | n | aOR (95% CI) | n | aOR (95% CI) | n | aOR (95% CI) |
Age b | 787 | 23 | 1.2 (1.0–1.3) | 14 | Not retained | 42 | 1.1 (1.0–1.2) |
TB prevalence in country of birth | |||||||
<20 cases per 100,000 pop. | 713 | 6 | 1.0 | 9 | 1.0 | 16 | 1.0 |
20–100 cases per 100,000 pop. | 23 | 3 | 14.4 (3.2–64.2) | 1 | 3.6 (0.4–29.3) | 5 | 12.4 (3.9–39.6) |
>100 cases per 100,000 pop. | 51 | 14 | 38.6 (13.7–109.0) | 4 | 7.0 (2.1–23.5) | 21 | 34.7 (15.2–79.2) |
Reactivity to M. avium PPD | |||||||
No | 725 | 19 | Not retained | 12 | Not retained | 32 | 1.0 |
Yes | 62 | 4 | 2 | 10 | 6.8 (2.6–17.5) |
N = total number of recruits with completed test and determinate results; n = the number or recruits with positive test results; TST = tuberculin skin test; QFT-GIT = QuantiFERON®-TB Gold In-Tube test; aOR (95% CI) = adjusted Odds Ratios (95% confidence intervals) with boldface font indicating statistically significant differences; TB = tuberculosis.
a TST induration >10 mm includes reactions >15 mm;
b Increase in odds for each year of age.